Overview
agilon health
?
#
681
Fortune 1000 Revenue Rank
Steven J Sell
See more contacts
Other Ambulatory Health Care Services
,
Ambulatory Health Care Services
,
Health Care and Social Assistance
,
Medical services organization
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Medical and Diagnostic Laboratories
,
Nursing Care Facilities (Skilled Nursing Facilities)
View more , Offices of Dentists , Offices of Other Health Practitioners , Offices of Physicians , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Dentists , Offices of Other Health Practitioners , Offices of Physicians , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
?
?
Modelled
?
Actual
$6.06 billion
Actual
40.41%
$1,733
DEC
?
?
NYSE:AGL
Contacts
Get in Touch with 6 Principals* and 279 Contacts
-
Steven J SellPresident and Chief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$6.06 billion
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | -$58 | -$156 | -$131 |
| Net Investing Cash | $140 | -$44 | -$444 |
| Net Financing Cash | -$3 | -$193 | $28 |
| Net Change in Cash | $80 | -$393 | -$547 |
| Cash at Beginning of Period | $114 | $508 | $1,055 |
| Cash at End of Period | $194 | $114 | $508 |
| Capital Expenditure | -$41 | -$31 | -$33 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $188 | $108 | $465 |
| Accounts Receivable | $1,017 | $942 | $492 |
| Inventories | $ | $ | $ |
| Other Current Assets | $253 | $430 | $494 |
| Asset Summary | |||
| Total Current Assets | $1,458 | $1,480 | $1,451 |
| Tangible Fixed Assets | $37 | $41 | $32 |
| Intangible Assets | $73 | $64 | $18 |
| Total Assets | $1,734 | $1,741 | $1,697 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $1,152 | $977 | $478 |
| Short-Term Debt | $ | $ | $5 |
| Other Current Liabilities | $ | $ | $52 |
| Liability Summary | |||
| Total Current Liabilities | $1,152 | $977 | $535 |
| Long-Term Debt | $35 | $32 | $38 |
| Other Long-Term Liabilities | $70 | $59 | $73 |
| Total Liabilities | $1,263 | $1,080 | $657 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $4 | $4 | $4 |
| Retained Earnings | -$1,587 | -$1,327 | -$1,064 |
| Equity Summary | |||
| Total Equity | $471 | $662 | $1,041 |
| Shares Outstanding | 412,194,000 | 406,387,000 | 412,385,000 |